Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does clopidogrel pretreatment counteract the benefits of off-pump CABG surgery?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mehta SR et al.; Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358: 527–533

    Article  CAS  Google Scholar 

  2. Hongo RH et al. (2002) The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 40: 231–237

    Article  CAS  Google Scholar 

  3. Stroobant N et al. (2005) Relation between neurocognitive impairment, embolic load, and cerebrovascular reactivity following on-and off-pump coronary artery bypass grafting. Chest 127: 1967–1976

    Article  Google Scholar 

  4. Jones RH (2006) The year in cardiovascular surgery. J Am Coll Cardiol 47: 2094–2107

    Article  Google Scholar 

  5. Akowuah E et al. (2005) Comparison of two strategies for the management of antiplatelet therapy during urgent surgery. Ann Thorac Surg 1: 149–152

    Article  Google Scholar 

  6. Mangano DT et al.; Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354: 353–365

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kimberley Skelding.

Ethics declarations

Competing interests

The Duke University catheterization laboratory conference that PB Berger directs has received unrestricted educational grants from Sanofi Aventis, Lilly, Sankyo, Datascope, Johnson and Johnson, The Medicine Company, Boston Scientific and Medtronic. He has received research support from Boehringer Ingelheim, Conor, Cardiokinetix and Guilford. He has spoken at scientific symposia supported by Bristol-Myers Squibb, Sanofi Aventis, Arginox and Schering Plough. He has served as a consultant to Johnson and Johnson, Boston Scientific, Genetech and Guilford. K Skelding declared she has no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Skelding, K., Berger, P. Does clopidogrel pretreatment counteract the benefits of off-pump CABG surgery?. Nat Rev Cardiol 3, 530–531 (2006). https://doi.org/10.1038/ncpcardio0652

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0652

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing